Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For HAE
Valuation Bad
0%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
33%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q3 Q4 Δ in %
Current Ratio -12.41 2.56 2.92
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -9.39 8.82 9.73
Naive Interpretation member
2 Per Share
Metric Q3 Q4 Δ in %
Book Value 1.73 18.90 18.58
Cash -7.54 3.55 3.84
Capex 56.57 -0.19 -0.44
Free Cash Flow 138.13 1.07 -0.45
Revenue 2.06 6.76 6.62
Naive Interpretation member
3 Profitability
Metric Q3 Q4 Δ in %
Gross Margin -5.50 0.50 0.53
Operating Margin 9.00 0.15 0.14
ROA -34.66 < 0.005 0.01
ROE -35.94 0.02 0.03
ROIC 39.34 0.03 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of HAE is permitted for members.
5 Growth
The "Growth Entry" for the Focus of HAE is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of HAE is permitted for members.